Viewing Study NCT03986294


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-01-24 @ 6:16 PM
Study NCT ID: NCT03986294
Status: UNKNOWN
Last Update Posted: 2021-01-15
First Post: 2019-02-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Liposomal irinotecan View
None S1 View
None Pancreatic cancer View
None Second line View